Table 7 Lipid panel data for 22 men and women assigned to Glavonoidâ„¢ or placebo for eight weeks.
Variable | Glavonoidâ„¢ Pre (n = 11) | Glavonoidâ„¢ Post (n = 11) | Placebo Pre (n = 11) | Placebo Post (n = 11) |
|---|---|---|---|---|
Cholesterol (mg·dL-1) | 184.5 ± 11.8 | 174.2 ± 10.2 | 158.4 ± 10.2 | 168.3 ± 12.9 |
Triglycerides (mg·dL-1) | 113.8 ± 16.8 | 98.2 ± 17.8 | 79.3 ± 16.6 | 71.0 ± 17.3 |
HDL-C (mg·dL-1) | 52.7 ± 3.1 | 52.8 ± 3.7 | 47.6 ± 6.3 | 48.0 ± 4.5 |
VLDL-C (mg·dL-1) | 22.7 ± 3.3 | 19.6 ± 3.5 | 16.0 ± 3.3 | 14.1 ± 3.4 |
LDL-C (mg·dL-1) | 109.1 ± 10.5 | 101.7 ± 9.2 | 94.8 ± 7.9 | 106.2 ± 11.0 |
LDL-C/HDL-C | 2.2 ± 0.3 | 2.1 ± 0.3 | 2.3 ± 0.4 | 2.4 ± 0.4 |
Total:HDL-C | 3.7 ± 0.4 | 3.5 ± 0.4 | 3.8 ± 0.5 | 3.8 ± 0.5 |
Free Fatty Acids (mmol·L-1) | 0.33 ± 0.05 | 0.36 ± 0.04 | 0.30 ± 0.04 | 0.23 ± 0.04 |